Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central anxious process, conolidine modulates alternate molecular targets. A Science Developments review discovered that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://franciscokwayg.theobloggers.com/45371175/the-2-minute-rule-for-conolidin-to-replace-traditional-painkillers